Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epicatechin gallate (ECG) is a **flavan-3-ol** type flavonoid, primarily found in green tea (*Camellia sinensis*), and is also present in cocoa, grapes, buckwheat, and other plants[1][2]. It is a **polyphenolic catechin** formed by the esterification of epicatechin with gallic acid. ECG is noted for its potent **antioxidant**, **antimicrobial**, **anti-inflammatory**, and **potential anticancer** activities. It acts as a nonselective antagonist of opioid receptors and inhibits bacterial efflux pumps (e.g., NorA in *Staphylococcus aureus*), contributing to the reduction of methicillin resistance and staphylococcal virulence[1][7]. In cancer models, ECG can induce apoptosis via caspase-3 activation and inhibit DNA methyltransferase, potentially reactivating tumor suppressor genes[1][2][8]. ECG modulates inflammatory mediators such as IL-6, TNF-α, and NF-κB, and has been studied for its potential role in modulating inflammation related to SARS-CoV-2 infection[1]. Its **bioavailability** is relatively poor due to low absorption and degradation by gut microbiota, and it is not established as a pharmaceutical drug; rather, it is used in biochemical, nutraceutical, and research contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on epicatechin gallate.